α-Secretase Activation – An Approach to Alzheimer’s Disease Therapy

Publisher： Karger

E-ISSN： 1660-2862|3|4-5|255-261

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.3, Iss.4-5, 2006-10, pp. : 255-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of γ-Secretase Inhibition on the Amyloid β Isoform Pattern in a Mouse Model of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 6, Iss. 5-6, 2009-12 ,pp. : 258-262

Karger

Access to resources Recommend Favorite

Engineered Heparins: Novel β-Secretase Inhibitors as Potential Alzheimer’s Disease Therapeutics

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 197-199

Karger

Access to resources Recommend Favorite

LXR-α genomics programmes neuronal death observed in Alzheimer’s disease

By Raina Ashvinder  

Apoptosis, Vol. 15, Iss. 12, 2010-12 ,pp. : 1461-1469

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer’s as a metabolic disease

By Demetrius Lloyd   Driver Jane  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Retromers in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. : 116-121

Karger

Access to resources Recommend Favorite